Jonathan Mcneill serves as Executive at Dyne Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Jonathan Mcneill has executed 52 insider transactions totaling $5.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 15, 2025 involved receiving (via award) 6,000 shares valued at $0.
Jonathan Mcneill currently holds 159,707 shares of Dyne Therapeutics, Inc. (DYN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jonathan Mcneill has been a net seller of DYN stock. They have purchased $0 and sold $5.6M worth of shares.
Jonathan Mcneill's most recent insider trade was on Dec 15, 2025, when they sold 6,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 19, 2024 | DYN | $108.0K | Sale | 2,400 | $45.01 | Planned |
| Aug 19, 2024 | DYN | $14.0K | Sale | 305 | $46.00 | Planned |
| Jun 11, 2024 | DYN | $57.1K | Sale | 1,823 | $31.34 | Discretionary |
| May 16, 2024 | DYN | $64.3K | Sale | 2,279 | $28.20 | Planned |
| May 16, 2024 | DYN | $14.2K | Sale | 495 | $28.59 | Planned |
| Mar 11, 2024 | DYN | $98.8K | Option Exercise | 17,825 | $5.54 | Planned |
| Mar 11, 2024 | DYN | $454.2K | Sale | 17,825 | $25.48 | Planned |
| Mar 11, 2024 | DYN | $45.7K | Sale | 1,776 | $25.71 | Planned |
| Mar 8, 2024 | DYN | $1.5M | Sale | 54,648 | $26.72 | Planned |
| Mar 8, 2024 | DYN | $477.3K | Option Exercise | 86,159 | $5.54 | Planned |
| Mar 8, 2024 | DYN | $21.3K | Option Exercise | 3,841 | $5.54 | Planned |
| Mar 8, 2024 | DYN | $882.5K | Sale | 34,663 | $25.46 | Planned |
| Mar 8, 2024 | DYN | $18.8K | Sale | 689 | $27.31 | Planned |
| Mar 7, 2024 | DYN | $62.9K | Sale | 2,434 | $25.85 | Planned |
| Mar 1, 2024 | DYN | $42.8K | Sale | 1,442 | $29.70 | Planned |
| Mar 1, 2024 | DYN | $253.3K | Sale | 8,715 | $29.06 | Planned |
| Mar 1, 2024 | DYN | $398.4K | Sale | 14,103 | $28.25 | Planned |
| Mar 1, 2024 | DYN | $17.7K | Option Exercise | 24,260 | $0.73 | Planned |
| Feb 29, 2024 | DYN | $117.4K | Sale | 4,268 | $27.50 | Planned |
| Feb 29, 2024 | DYN | $3.1K | Option Exercise | 4,268 | $0.73 | Planned |
| Jan 26, 2024 | DYN | $486.0K | Sale | 19,822 | $24.52 | Planned |
| Jan 26, 2024 | DYN | $4.5K | Sale | 178 | $25.14 | Planned |
| Jan 26, 2024 | DYN | $14.6K | Option Exercise | 20,000 | $0.73 | Planned |
| Jan 4, 2024 | DYN | $36.2K | Sale | 2,009 | $18.04 | Planned |
| Jan 4, 2024 | DYN | $1.5K | Option Exercise | 2,009 | $0.73 | Planned |
| Jan 3, 2024 | DYN | $141.1K | Sale | 7,691 | $18.34 | Planned |
| Jan 3, 2024 | DYN | $13.1K | Option Exercise | 17,991 | $0.73 | Planned |
| Jan 3, 2024 | DYN | $196.0K | Sale | 10,300 | $19.03 | Planned |